Literature DB >> 12204293

Brain-specific endothelial induction of prostaglandin E(2) synthesis enzymes and its temporal relation to fever.

Wataru Inoue1, Kiyoshi Matsumura, Kanato Yamagata, Takako Takemiya, Takuma Shiraki, Shigeo Kobayashi.   

Abstract

Brain endothelial cells are hypothesized to be the major source of prostaglandin E(2) (PGE(2)) responsible for fever because they express 2 PGE(2)-synthesizing enzymes (cyclooxygenase-2 and microsomal-type PGE synthase) in response to pyrogens. To further validate this hypothesis, we examined in rats whether endothelial expression of these enzymes occurs only in the brain, and whether the time course of enzyme expression in brain endothelial cells can explain the time courses of brain PGE(2) level and fever. Intraperitoneal injection of lipopolysaccharide induced these enzymes only in brain endothelial cells, but not in those of peripheral organs including the neck, heart, lung, liver and kidney. Induction of these enzymes in brain endothelial cells was first noticed at 1.5 h after lipopolysaccharide injection, at which time elevation of PGE(2) was also first detected. Fever started just after this time point. These results demonstrate the significance of brain endothelial cells in the PGE(2) production during fever. Unexpectedly, PGE(2) level markedly dropped at 5 h in spite of high levels of these enzymes, implicating the existence of an unknown mechanism that suppresses PGE(2) level during the recovery phase of fever.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204293     DOI: 10.1016/s0168-0102(02)00083-4

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  16 in total

Review 1.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

2.  Drug transport into the central nervous system: using newer findings about the blood-brain barriers.

Authors:  William A Banks
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

3.  Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain.

Authors:  Pierre-Olivier Hétu; Denis Riendeau
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

4.  Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra.

Authors:  Hey-Kyeong Jeong; Ilo Jou; Eun-hye Joe
Journal:  Exp Mol Med       Date:  2010-12-31       Impact factor: 8.718

Review 5.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

Review 6.  Neural circuitry engaged by prostaglandins during the sickness syndrome.

Authors:  Clifford B Saper; Andrej A Romanovsky; Thomas E Scammell
Journal:  Nat Neurosci       Date:  2012-07-26       Impact factor: 24.884

Review 7.  The blood-brain barrier as an endocrine tissue.

Authors:  William A Banks
Journal:  Nat Rev Endocrinol       Date:  2019-08       Impact factor: 43.330

8.  Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole.

Authors:  Shin-Ichi Akanuma; Yasuo Uchida; Sumio Ohtsuki; Masanori Tachikawa; Tetsuya Terasaki; Ken-Ichi Hosoya
Journal:  Fluids Barriers CNS       Date:  2011-10-21

9.  Cellular and molecular bases of the initiation of fever.

Authors:  Alexandre A Steiner; Andrei I Ivanov; Jordi Serrats; Hiroshi Hosokawa; Allison N Phayre; Jared R Robbins; Jennifer L Roberts; Shigeo Kobayashi; Kiyoshi Matsumura; Paul E Sawchenko; Andrej A Romanovsky
Journal:  PLoS Biol       Date:  2006-09       Impact factor: 8.029

Review 10.  Intercellular signaling pathway among Endothelia, astrocytes and neurons in excitatory neuronal damage.

Authors:  Takako Takemiya; Kanato Yamagata
Journal:  Int J Mol Sci       Date:  2013-04-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.